Implantable cardioverter defibrillators for prevention of sudden cardiac death

Clinical Cardiology

Volumn 30, Issue 1, 2007, Pages 3-8

  Sukhija, Rishi ^a   Mehta, Vimal ^b   Leonardi, Marino ^a   Mehta, Jawahar L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b G B PANT HOSPITAL   (India)

Author keywords

Congestive heart failure; Coronary artery disease; Implantable cardioverter defibrillators; Left ventricular ejection fraction; Sudden cardiac death

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLECAINIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROPAFENONE;

ALGORITHM; AUTOMATION; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEFIBRILLATOR; ELECTROPHYSIOLOGY; HEART ARREST; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; PATHOPHYSIOLOGY; PRIMARY PREVENTION; REVIEW; RISK ASSESSMENT; SUDDEN DEATH;

ADULT; AGED; CARDIOMYOPATHY, DILATED; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS; DEFIBRILLATORS, IMPLANTABLE; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; MIDDLE AGED; RISK ASSESSMENT;

EID: 33846407994     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20001     Document Type: Review

References (43)

1. Zipes DP, Wellens HJ: Sudden cardiac death. Circulation 1998;98:2334-2351
2. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, et al.: Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2001;22:1314-1450
3. Zheng ZJ, Croft JB, Giles WH, Mensah GA: Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104:2158-2163
4. American Heart Association website. Sudden deaths from cardiac arrest statistics. Available at: https://www.americanheart.org. Accessed July 21, 2005
5. Spooner PM, Albert C, Benjamin EJ, Boineau R, Elston RC, et al.: Sudden cardiac death, genes and arrhythmogenesis: Consideration of new population and mechanistic approaches from a National Heart, Lung and Blood Institute workshop, part I. Circulation 2001;103:2361-2364
6. Myerburg RJ, Castellanos A: Cardiac arrest and sudden cardiac death. In Heart Disease: A Textbook of Cardiovascular Medicine 7th ed. (Eds. Zipes DP, Libby P, Bonow RO, Braunwald E) pp.865-908. Philadelphia: WB Saunders, 2005
7. Padeletti L, Giaccardi M, Turreni F, Musilli N, Colella A, et al.: Influence of QRS prolongation on the natural history of CHF. Eur Heart J 2004;6(suppl D):D79-D82
8. Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, et al.: Heart rate profile during exercise as a predictor of sudden death. N Engl J Med 2005;352:1951-1958
9. 9. Armoundas AA, Hohnloser SH, Ikeda T, Cohen RJ: Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation? Nat Clin Pract Cardiovasc Med 2005;2:522-528
10. Morgan JM: Patients with ventricular arrhythmias: Who should be referred to an electrophysiologist? Heart 2002;88:544-550
11. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, et al.: for the Cardiac Arrhythmia Suppression Trial Investigators: Mortality and morbidity in patients receiving encainide, flecainide, or placebo: The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-788
12. Beta-Blocker Heart Attack Trial Research Group: A randomized trial of propranolol in patients with acute myocardial infarction, I: Mortality results. J Am Med Assoc 1982;247:1707-1714
13. Brodine WN, Tung RT, Lee JK, Hockstad ES, Moss AJ, et al.: for the MADIT-II Research Group: Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II). Am J Cardiol 2005;96:691-695
14. Boutitie F, Boissel JP, Connolly SJ, Camm AJ, Cairns JA, J et al.: for the EMIAT and CAMIAT Investigators: Amiodarone interaction with beta-blockers: Analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. Circulation 1999;99:2268-2275
15. Domanski MJ, Exner DV, Borkowf CB, Geller NL, Rosenberg Y, et al.: Effect of angiotensin converting enzyme inhibition on sudden death in patients following acute myocardial infarction: A meta-analysis of randomized clinical trials. J Am Coll Cardiol 1999;33:598-604
16. Lindholm LH, Dahlof B, Edelman JM, Ibsen H, Borch-Johnsen K, et al.: and the LIFE study group: Effect of losartan on sudden cardiac death in people with diabetes: Data from the LIFE study. Lancet 2003;362:619-620
17. Pitt B, Gheorghiade M, Zannad F, Anderson JL, van Veldhuisen DJ, et al.: On behalf of the EPHESUS Investigators: Evaluation of eplerenonein the subgroup of EPHESUS patients with baseline left ventricular ejection fraction ≤ 30%. Eur J Heart Fail 2006;8:295-301
18. Makikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, et al.: Frequency of sudden cardiac death among acute myocardial infarction survivors with optimized medical and revascularization therapy. Am J Cardiol 2006;97:480-484
19. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1584
20. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, et al.: Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302
21. Kuck KH, Cappato R, Siebels J, Ruppel R: Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-754
22. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, et al.: Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials: AVID, CASH and CIDS studies. Eur Heart J 2000;21: 2071-2078
23. Bokhari F, Newman D, Greene M, Korley V, Mangat I, et al.: Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: Eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation 2004;110:112-116
24. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, et al.: Improved survival with an implantable defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940
25. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, et al.: A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-1890
26. [Erratum, N Engl J Med 2000;342:1300]
27. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, et al.: for the Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883
28. Wilber DJ, Zareba W, Hall WJ, Brown MW, Lin AC, et al.: Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 2004;109:1082-1084
29. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, et al.: for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352;225-231
30. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, et al.: for the Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators, Valsartan in Acute Myocardial Infarction Trial Investigators: Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005;352:2581-2588
31. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, et al.: for the DINAMIT Investigators: Prophylactic use of an implantable cardioverter- defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-2488
32. Centers for Medicare & Medicaid Services Web site. Available at: https://www.cms.hhs.gov. Accessed January 19, 2006
33. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, et al.: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival: Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995;333:77-82
34. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, et al.: Randomized trial of low dose amiodarone in severe congestive heart failure: Grupo de Estudio de la Sobre vida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994;344:493-498
35. Bansch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, et al.: Primary prevention of sudden death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial. Circulation 2002;105:1453-1458
36. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, et al.: for the AMIOVIRT Investigators: Amiodarone versus implantable cardioverter-defibrillator. Randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT. J Am Coll Cardiol 2003;41:1707-1712
37. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, et al: for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation Investigators: Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-2158
38. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, et al.: for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators: Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150
39. American Heart Association and International Liaison Committee on Resuscitation: Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2000;102(suppl 1):160-176
40. Hallstrom A, Omato JP, for The Public Access Defibrillation Trial Investigators: Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med 2004;351:637-646
41. Davies CS, Colquhoun MC, Boyle R, Chamberlain DA: A national programme for on-site defibrillation by lay people in selected high-risk areas. Heart 2005;91:1299-1302
42. Stiell IG, Wells GA, Field B, Spaite DW, Nesbitt LP, et al.: for the Ontario Prehospital Advanced Life Support Study Group: Advanced cardiac life support in out-of-hospital cardiac arrest. N Engl J Med 2004;351:647-656
43. Bigger JT Jr, for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators: Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 1997;337:1569-1575